Ftse Mib
38.005,26
-0,79%
DAX
22.567,14
-0,44%
S&P 500
5.510,85
-1,58%
NASDAQ
17.259,46
-2,20%
Bitcoin
80.256,70
-4,09%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cellectar Biosciences Inc (CLRB) Cellectar Biosciences Inc (CLRB) Notizie

Cellectar Biosciences Inc

CLRB
0,284
-0,0326 (-10,30%)
Ultimo aggiornamento: 18:17:17
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/3/202512:15EDGAR2Form 8-K - Current report
13/3/202512:05GLOBECellectar Biosciences Reports Financial Results for Year..
13/3/202511:50EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
13/3/202502:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202513:05GLOBECellectar Biosciences to Present at the 37th Annual Roth..
05/3/202514:05GLOBECellectar Biosciences to Report Full Year Financial Results..
18/2/202522:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202522:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202522:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202522:32EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
07/2/202522:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/2/202514:05GLOBECellectar Biosciences to Present at the Oppenheimer 35th..
03/2/202522:57EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
31/1/202522:30EDGAR2Form 8-K - Current report
29/1/202522:16EDGAR2Form S-1 - General form for registration of securities under..
14/1/202512:01EDGAR2Form 8-K - Current report
13/1/202500:00GLOBECellectar Biosciences to Highlight 2025 Strategic..
10/12/202423:00GLOBECellectar Biosciences Provides Strategic Update on Clinical..
18/11/202413:15EDGAR2Form 8-K - Current report
18/11/202413:05GLOBECellectar Biosciences Reports Financial Results for Q3 2024..
18/11/202412:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/11/202422:33EDGAR2Form 8-K - Current report
14/11/202422:47EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202414:05GLOBECellectar Biosciences and NorthStar Medical Radioisotopes..
13/11/202422:45EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
12/11/202414:05GLOBECellectar Biosciences and SpectronRx Partner to Manufacture..
11/11/202422:05GLOBECellectar Biosciences to Report Third Quarter Financial..
07/11/202412:40GLOBECellectar Selected to Present New Data from Phase 2..
01/11/202422:15EDGAR2Form 8-K - Current report
01/11/202422:00GLOBECellectar Biosciences Announces Compliance Regarding Filing..
29/10/202422:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/10/202422:03EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
29/10/202421:56EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
26/8/202412:40GLOBEIopofosine I 131 Featured in Two Separate Presentations at..
23/8/202423:15EDGAR2Form 8-K - Current report
23/8/202423:00GLOBECellectar to Restate Previously Issued Financial Statements..
15/8/202401:15EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/8/202423:00EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
13/8/202412:45EDGAR2Form 8-K - Current report
13/8/202412:40GLOBECellectar Biosciences Reports Financial Results for Q2 2024..
09/8/202423:00EDGAR2Form 8-K - Current report
08/8/202423:15GLOBEUPDATE -- Cellectar Biosciences to Announce Second Quarter..
08/8/202422:05GLOBECellectar Biosciences to Announce First Quarter Financial..
23/7/202412:45EDGAR2Form 8-K - Current report
23/7/202412:40GLOBECellectar Biosciences’ Iopofosine I 131 Exceeds Primary..
22/7/202412:45EDGAR2Form 8-K - Current report
22/7/202412:40GLOBECellectar Biosciences Announces Exercise of Tranche B..
11/7/202423:37EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
Apertura: 0,3196 Min: 0,284 Max: 0,3196
Chiusura: 0,3166

La tua Cronologia

NASDAQ
CLRB
Cellectar Biosciences
LSE
IHG
Intercontinental Hotels
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci